Results 11 to 20 of about 209,522 (357)

Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2 [PDF]

Clinical Chemistry, 2021
BackgroundIt is unknown whether a positive serology result correlates with protective immunity against SARS-CoV-2. There are also concerns regarding the low positive predictive value of SARS-CoV-2 serology tests, especially when testing populations with ...
Raymond T Suhandynata, Deli Huang, Michael J Kelner   +2 more
exaly   +3 more sources

Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy

Pathogens, 2022
Understanding the local burden and epidemiology of infectious diseases is crucial to guide public health policy and prioritize interventions. Typically, infectious disease surveillance relies on capturing clinical cases within a healthcare system ...
Andrea Haßelbeck, Justin Im, Florian Marks   +2 more
exaly   +2 more sources

The HPV Serology Laboratory leads an initiative to standardize and harmonize human papillomavirus serology assays

PLoS Pathogens, 2023
The HPV Serology Laboratory is leading a global partnership initiative aiming for standardization and harmonization of current serology assay platforms being used to assess immune responses to HPV vaccines.
Troy J Kemp, Ligia A Pinto
exaly   +2 more sources

Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients

Emerging Microbes and Infections, 2020
Effective strategy to mitigate the ongoing pandemic of 2019 novel coronavirus (COVID-19) require a comprehensive understanding of humoral responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the emerging virus causing COVID-19.
Xudong Shi, Yuxin Chen, Bing Gu
exaly   +2 more sources

Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals

Emerging Microbes and Infections, 2020
Serology detection is recognized for its sensitivity in convalescent patients with COVID-19, in comparison with nucleic acid amplification tests (NAATs).
Michael J Loeffelholz, , Wenhong Zhang
exaly   +2 more sources

Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology

Clinical Biochemistry, 2020
Highlights • SARS-CoV-2 serology offers limited clinical utility for individuals.• SARS-CoV-2 serology may be useful for seroprevalence studies.• Claims regarding protective immunity or infectivity cannot be made using serology.• Assay clinical ...
Vilte Barakauskas, Paul M Yip, Vathany Kulasingam   +2 more
exaly   +2 more sources

Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology

Cell, 2020
Analysis of the specificity and kinetics of neutralizing antibodies (nAbs) elicited by SARS-CoV-2 infection is crucial for understanding immune protection and identifying targets for vaccine design.
Y. Park, M. A. Tortorici, A. Walls, N. Czudnochowski, G. Snell, D. Veesler   +5 more
semanticscholar   +2 more sources

Finding Needle in the Haystack: “Kasur’s Bogeyman” Brought to Justice by Geographic Profiling and Mass DNA Screening

Brazilian Journal of Forensic Sciences, Medical Law and Bioethics, 2021
This article describes the application of the concept of geographic profiling in hunting a serial child rapist in Kasur, Pakistan. It also discusses, how DNA became the prime witness against the serial rapist in the court of law.
Muhammad Ahsan Butt, Talha Bin Rahat, Nasir Siddique, Madiha Shad, Sajjad Ahmad, Qazi Laeeque Ahmed, Muhammad Amjad, Mohammad Ashraf Tahir   +7 more
doaj   +1 more source

Implementation of Novel Quality Assurance Program for Hepatitis C Viral Load Point of Care Testing

Viruses, 2022
All patients should have access to accurate and timely test results. The introduction of point of care testing (PoCT) for infectious diseases has facilitated access to those unable to access traditional laboratory-based medical testing, including those ...
Wayne Dimech, Liza Cabuang, Kylie Davies, Giuseppe Vincini   +3 more
doaj   +1 more source

Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT–PCR

Infectious Disease and Therapy, 2023
Nearly all existing respiratory syncytial virus (RSV) incidence estimates are based on real-time polymerase chain reaction (RT–PCR) testing of nasal or nasopharyngeal (NP) swabs. Adding testing of additional specimen types to NP swab RT–PCR increases RSV
Julio A Ramirez, R. Carrico, Ashley M. Wilde, A. Junkins, S. Furmanek, T. Chandler, Paul S. Schulz, Robin Hubler, P. Peyrani, Qing Liu, Sonali Trivedi, S. Uppal, W. Kalina, A. Falsey, E. Walsh, K. Yacisin, L. Jodar, B. Gessner, Elizabeth Begier   +18 more
semanticscholar   +1 more source